Co-Chief Executive Officer
Myeloma Patients Europe
Kate Morgan is co-Chief Executive Officer at Myeloma Patients Europe, an umbrella organisation of myeloma and AL amyloidosis patient groups across Europe. MPE's mission is to provide education, information, and support to member organisations and to advocate at European, national, and local levels for the best possible research and equal access to treatment and care.
Kate holds a Bachelor’s degree in Government from the London School of Economics and Political Sciences and a Master’s degree in International and European Politics from the University of Edinburgh. She also holds a Diploma in Public Relations from the Chartered Institute for Public Relations. Her main area of interest is health policy, specifically focusing on policies affecting drug development and access in European countries.
Kate previously worked for eight years in the Policy Team at Myeloma UK, where she was involved in influencing a range of policy and reimbursement decisions affecting myeloma patients’ access to good quality care and effective new drugs. She was involved in several patient and public advisory panels in the UK healthcare system, including for the Scottish Medicines Consortium, the drug approval body in Scotland.
She has been involved in a wide range of patient organisation networks, both nationally and internationally – most recently chairing the Blood Cancers Alliance, an information-sharing network of haematological cancer charities in the UK.
Kate currently lives and works in Edinburgh, Scotland.